CGRP and the Trigeminal System in Migraine
Smriti Iyengar(National Institute of Neurological Disorders and Stroke), Sheena K. Aurora(Impel Neuropharma (United States))
Cited by 483
Related Papers
Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine
|Brain|2019|275
Research designs for proof-of-concept chronic pain clinical trials: IMMPACT recommendations
|Pain|2014|110
Peripheral effects of three novel non-peptide tachykinin NK1 receptor antagonists in the anaesthetized rat
|European Journal of Pharmacology|1996|15